Search

Search Results
Results 2011 - 2020 of 2867 for Bowel Cancer
  • Drug - 31 Oct 2025
    Consumer Medicine Information (CMI) about Giotrif intended for persons living in Australia.
  • Drug - 23 Oct 2025
    Consumer Medicine Information (CMI) about Mizart HCT (New) intended for persons living in Australia.
  • Drug - 9 Oct 2025
    Consumer Medicine Information (CMI) about Cabometyx intended for persons living in Australia.
  • Drug - 3 Oct 2025
    Consumer Medicine Information (CMI) about DBL Docetaxel intended for persons living in Australia.
  • Drug - 19 Sep 2025
    Consumer Medicine Information (CMI) about DBL Cisplatin Injection intended for persons living in Australia.
  • News - 25 Aug 2025
    Researchers led by Hiroshi Ohno at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have discovered why smoking tobacco helps people suffering from ulcerative colitis, a chronic...
  • Drug - 30 Jul 2025
    Consumer Medicine Information (CMI) about Augtyro intended for persons living in Australia.
  • White Paper - 24 Jul 2025
    Discover how targeted therapies are revolutionizing autoimmune disease treatment by offering greater precision.
  • Drug - 18 Jul 2025
    Consumer Medicine Information (CMI) about Zavedos intended for persons living in Australia.
  • News - 22 Mar 2025
    A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease, according to findings published in Science Immunology on March 21.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.